Androgens in postmenopausal women: a review

@article{Shifren2017AndrogensIP,
  title={Androgens in postmenopausal women: a review},
  author={Jan L. Shifren and Susan R. Davis},
  journal={Menopause},
  year={2017},
  volume={24},
  pages={970–979}
}
Abstract There is significant interest in the use of androgen therapy for postmenopausal women. This review provides background on endogenous androgens in women, describes factors that affect circulating androgen concentrations, and examines the relationship between low levels of androgens and sexual problems. Possible effects of androgens in postmenopausal women beyond sexual function also are discussed. Clinical trials of androgen therapy for the treatment of hypoactive sexual desire disorder… 
Sexual Function in Postmenopausal Women and Serum Androgens: A Review Article
TLDR
Androgens may affect sexual function; however, androgen therapy, as an option for improving sexual function in menopause, needs further research.
Testosterone in Females
Although testosterone (T) is known for being the major sex hormone in males, androgens circulate at relatively high levels also in women throughout their lifespan, playing an important role in
Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women.
TLDR
Testosterone trials in women have been limited by homogeneity in the study populations and outcomes measured, and the regulatory agency had posed a challenge to approve any testosterone treatment for women based on unproven concerns and a lack of regulatory guidance for drug developers.
Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women
TLDR
The addition of low-dose testosterone gel to daily estrogen may improve sexual function in postmenopausal women, but further evaluation and safety data are needed.
Detrimental Effects of Testosterone Addition to Estrogen Therapy Involve Cytochrome P-450-Induced 20-HETE Synthesis in Aorta of Ovariectomized Spontaneously Hypertensive Rat (SHR), a Model of Postmenopausal Hypertension
TLDR
It is shown that association of testosterone to estrogen therapy produces detrimental effects in cardiovascular system of ovariectomized hypertensive females via CYP4F3/20-HETE pathway, which supports the standpoint that the CYP/ 20-HetE pathway is an important therapeutic target for the prevention of cardiovascular disease in menopausal women in the presence of high levels of testosterone.
Evolutionary Perspectives on Hypoactive Sexual Desire Disorder in Women
This review attempts to explain female hypoactive sexual desire disorder (HSDD) from a functional evolutionary perspective. Can theory and data regarding the evolved functions of female sexual
Can Vitamin D supplementation alone effective to increase a physical fitness levels in post-menopausal women with metabolic disorders? Brief Review.
TLDR
Doses less than 1000 IU/d did not show significant changes in physical fitness on post-menopausal women with metabolic diseases or not, and the effectiveness depends on the amount was prescribed for supplementation and the patient's characteristics.
Sexual Dysfunction in Women With Kidney Disease.
TLDR
Information is reviewed on the pathophysiology, clinical manifestations, and treatment for sexual dysfunction in women with CKD and ESKD, which is underrecognized secondary to a variety of factors.
Sex steroid hormones and risk of breast cancer incidence and survival: A two-sample Mendelian randomization study
TLDR
TT, BT, DHEAS and estradiol increase the risk of ER+ type BCs similar to observational studies, but none of these hormone measures are associated with BC survival, and some evidence that cortisol reduced ER- BC survival is found.
Androgen Plays a Carcinogenic Role in EOC via the PI3K/AKT Signaling Pathway in an AR-Dependent Manner
TLDR
It is shown that testosterone was able to promote the proliferation of ovarian cancer cells through activating the PI3K/AKT signaling pathway in an AR dependent manner and AR may be a screening indicator for anti-androgen therapy sensitive cases of EOC.
...
1
2
3
...

References

SHOWING 1-10 OF 76 REFERENCES
Is there a correlation between androgens and sexual desire in women?
TLDR
Sexual desire correlated overall with FT and androstenedione in the total cohort of women and ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgen levels by mass spectrometry.
Androgens and cardiovascular disease in postmenopausal women: a systematic review
TLDR
There is evidence of a favorable effect of androgens on surrogate cardiovascular markers in postmenopausal women, such as high density lipoprotein cholesterol, total cholesterol, body fat mass and triglycerides, and the cardiovascular effect of testosterone or methyltestosterone with or without concomitant estrogens needs to be elucidated.
Testosterone in women--the clinical significance.
TLDR
Clinical trials suggest that exogenous testosterone enhances cognitive performance and improves musculoskeletal health in postmenopausal women and unmet needs include the availability of approved testosterone formulations for women and studies to elucidate the contribution of testosterone to cardiovascular, cognitive, and musculosity health and the risk of cancer.
Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.
TLDR
It was clear that exogenous androgen enhanced the intensity of sexual desire and arousal and the frequency of sexual fantasies in hysterectomized and oophorectomization women, but there was no evidence that testosterone affected physiologic response or interpersonal aspects of sexual behavior.
Testosterone for midlife women: the hormone of desire?
TLDR
Clinical trial evidence is reported, risks are reviewed, and how testosterone might be used in a clinical setting is explained, for women who may be considering a trial of testosterone therapy.
DHEA replacement for postmenopausal women: placebo or panacea?
  • J. Eden
  • Medicine
    Climacteric : the journal of the International Menopause Society
  • 2015
TLDR
In adults, dehydroepiandrosterone (DHEA) is the most abundant steroid found in serum and its levels fall with age, and it may be considered to be a pro-hormone.
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study
TLDR
Testosterone patch treatment increased the frequency of satisfying sexual activity and sexual desire, decreased personal distress, and was well tolerated in naturally menopausal women with hypoactive sexual desire disorder.
Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
TLDR
Surgically menopausal women with HSDD in these studies received clinically meaningful benefits, including improvements in satisfying sexual activity, sexual desire, and personal distress.
Testosterone for low libido in postmenopausal women not taking estrogen.
TLDR
In postmenopausal women not receiving estrogen therapy, treatment with a patch delivering 300 microg of testosterone per day resulted in a modest but meaningful improvement in sexual function.
Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
TLDR
Increased circulating levels of unbound testosterone and suppression of SHBG provide a plausible hormonal explanation for the significantly improved sexual functioning in women receiving the combination of esterified estrogen and methyltestosterone.
...
1
2
3
4
5
...